Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Effect of n-3 Polyunsaturated Fatty Acids on Regression of Coronary Atherosclerosis in Statin Treated Patients Undergoing Percutaneous Coronary Intervention.

Ahn J, Park SK, Park TS, Kim JH, Yun E, Kim SP, Lee HW, Oh JH, Choi JH, Cha KS, Hong TJ, Lee SY, Lee HC.

Korean Circ J. 2016 Jul;46(4):481-9. doi: 10.4070/kcj.2016.46.4.481. Epub 2016 Jul 21.

2.

ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies.

Del Gobbo LC, Imamura F, Aslibekyan S, Marklund M, Virtanen JK, Wennberg M, Yakoob MY, Chiuve SE, Dela Cruz L, Frazier-Wood AC, Fretts AM, Guallar E, Matsumoto C, Prem K, Tanaka T, Wu JH, Zhou X, Helmer C, Ingelsson E, Yuan JM, Barberger-Gateau P, Campos H, Chaves PH, Djoussé L, Giles GG, Gómez-Aracena J, Hodge AM, Hu FB, Jansson JH, Johansson I, Khaw KT, Koh WP, Lemaitre RN, Lind L, Luben RN, Rimm EB, Risérus U, Samieri C, Franks PW, Siscovick DS, Stampfer M, Steffen LM, Steffen BT, Tsai MY, van Dam RM, Voutilainen S, Willett WC, Woodward M, Mozaffarian D; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Fatty Acids and Outcomes Research Consortium (FORCe).

JAMA Intern Med. 2016 Aug 1;176(8):1155-66. doi: 10.1001/jamainternmed.2016.2925.

PMID:
27357102
3.

N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis.

Chen GC, Yang J, Eggersdorfer M, Zhang W, Qin LQ.

Sci Rep. 2016 Jun 16;6:28165. doi: 10.1038/srep28165.

4.

The 2015 Dutch food-based dietary guidelines.

Kromhout D, Spaaij CJ, de Goede J, Weggemans RM.

Eur J Clin Nutr. 2016 Aug;70(8):869-78. doi: 10.1038/ejcn.2016.52. Epub 2016 Apr 6. Review.

5.

Nutrient reference value: non-communicable disease endpoints--a conference report.

Lupton JR, Blumberg JB, L'Abbe M, LeDoux M, Rice HB, von Schacky C, Yaktine A, Griffiths JC.

Eur J Nutr. 2016 Mar;55 Suppl 1:S1-10. doi: 10.1007/s00394-016-1195-z.

6.

EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4.

Eclov JA, Qian Q, Redetzke R, Chen Q, Wu SC, Healy CL, Ortmeier SB, Harmon E, Shearer GC, O'Connell TD.

J Lipid Res. 2015 Dec;56(12):2297-308. doi: 10.1194/jlr.M062034. Epub 2015 Oct 4.

7.

The influence of dietary fat source on liver and skeletal muscle mitochondrial modifications and lifespan changes in calorie-restricted mice.

Villalba JM, López-Domínguez JA, Chen Y, Khraiwesh H, González-Reyes JA, Del Río LF, Gutiérrez-Casado E, Del Río M, Calvo-Rubio M, Ariza J, de Cabo R, López-Lluch G, Navas P, Hagopian K, Burón MI, Ramsey JJ.

Biogerontology. 2015 Oct;16(5):655-70. doi: 10.1007/s10522-015-9572-1. Epub 2015 Apr 10. Review.

8.

Do omega-3 polyunsaturated Fatty acids prevent cardiovascular disease? A review of the randomized clinical trials.

Kimmig LM, Karalis DG.

Lipid Insights. 2013 Apr 16;6:13-20. doi: 10.4137/LPI.S10846. eCollection 2013. Review.

9.

The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis.

Enns JE, Yeganeh A, Zarychanski R, Abou-Setta AM, Friesen C, Zahradka P, Taylor CG.

BMC Cardiovasc Disord. 2014 May 31;14:70. doi: 10.1186/1471-2261-14-70. Review.

10.

Baseline plasma fatty acids profile and incident cardiovascular events in the SU.FOL.OM3 trial: the evidence revisited.

Fezeu LK, Laporte F, Kesse-Guyot E, Andreeva VA, Blacher J, Hercberg S, Galan P.

PLoS One. 2014 Apr 7;9(4):e92548. doi: 10.1371/journal.pone.0092548. eCollection 2014.

11.
12.

Selective and potent inhibitory effect of docosahexaenoic acid (DHA) on U46619-induced contraction in rat aorta.

Sato K, Chino D, Kobayashi T, Obara K, Miyauchi S, Tanaka Y.

J Smooth Muscle Res. 2013;49:63-77.

13.

Increased bruising with the combination of long-chain omega-3 fatty acids, flaxseed oil and clopidogrel.

Necyk C, Ware MA, Arnason JT, Tsuyuki RT, Boon H, Vohra S.

Can Pharm J (Ott). 2013 Mar;146(2):93-6. doi: 10.1177/1715163513481325. No abstract available.

14.

Exploratory analysis on the use of statins with or without n-3 PUFA and major events in patients discharged for acute myocardial infarction: an observational retrospective study.

Macchia A, Romero M, D'Ettorre A, Tognoni G, Mariani J.

PLoS One. 2013 May 6;8(5):e62772. doi: 10.1371/journal.pone.0062772. Print 2013. Erratum in: PLoS One. 2015;10(4):e0126303.

15.

Evaluation of suppressive and pro-resolving effects of EPA and DHA in human primary monocytes and T-helper cells.

Jaudszus A, Gruen M, Watzl B, Ness C, Roth A, Lochner A, Barz D, Gabriel H, Rothe M, Jahreis G.

J Lipid Res. 2013 Apr;54(4):923-35. doi: 10.1194/jlr.P031260. Epub 2013 Jan 24.

16.

Omega-3 Fatty acids and vitamin d in cardiology.

Güttler N, Zheleva K, Parahuleva M, Chasan R, Bilgin M, Neuhof C, Burgazli M, Niemann B, Erdogan A, Böning A.

Cardiol Res Pract. 2012;2012:729670. doi: 10.1155/2012/729670. Epub 2012 Dec 31.

17.

Omega-3 polyunsaturated fatty acids and cardiac rhythm: an introduction.

Billman GE.

Front Physiol. 2012 Dec 6;3:457. doi: 10.3389/fphys.2012.00457. eCollection 2012. No abstract available.

18.

Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

Marchioli R, Levantesi G.

Front Physiol. 2012 Jun 28;3:202. doi: 10.3389/fphys.2012.00202. eCollection 2012.

19.

The effects of dietary intervention on HIV dyslipidaemia: a systematic review and meta-analysis.

Stradling C, Chen YF, Russell T, Connock M, Thomas GN, Taheri S.

PLoS One. 2012;7(6):e38121. doi: 10.1371/journal.pone.0038121. Epub 2012 Jun 11. Review.

20.

Omega-3 Fatty acids: anti-arrhythmic, pro-arrhythmic, or both?

von Schacky C.

Front Physiol. 2012 Apr 17;3:88. doi: 10.3389/fphys.2012.00088. eCollection 2012.

Supplemental Content

Support Center